Penile metastases are rare in occurrence and are usually secondary to other genitourinary primary tumours. It is a debilitating near terminal condition at presentation with a dismal prognosis and poor survival rates. Supportive and palliative care is generally recommended to improve the quality of life of patients. We present a case of penile metastases in a 74-year-old male patient with prostatic adenocarcinoma in association with multiple skeletal metastases.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606275 | PMC |
| http://dx.doi.org/10.7860/JCDR/2015/14775.6421 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Real-World Outcomes in Patients with Advanced Penile Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Single Institution Experience.
J Immunother Precis Oncol
February 2025
Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.
Introduction: Advanced penile squamous cell carcinoma (pSCC) is a rare and aggressive malignancy with a poor prognosis and an unmet need for biomarkers. We performed a retrospective evaluation of real-world efficacy, safety outcomes, and baseline inflammatory biomarkers in patients with advanced pSCC treated with immune checkpoint inhibitors (ICIs).
Methods: We performed a retrospective review of patients with advanced pSCC who received ICIs from 2012 to 2023 at the Winship Cancer Institute of Emory University in Atlanta, GA.
An Unusual Presentation of Gastric Cancer Metastatic to the Penile Shaft and Perineum.
Cureus
November 2024
Radiation Oncology, Garnet Health, Middletown, USA.
Article Synopsis
- A 69-year-old Jamaican male with initially diagnosed gastric adenocarcinoma underwent standard treatment, including surgical resection and chemoradiation.
- Two years later, he experienced dyspareunia and was found to have penile skin changes, leading to a diagnosis of metastatic gastric cancer.
- After receiving chemotherapy and salvage radiotherapy, he was monitored for 15 months but eventually lost to follow-up and passed away.
Factor associated with postoperative complications of inguinal lymph node dissection for penile cancer Test.
Urol Ann
October 2024
Department of Surgery, Division of Urology, Phramongkutklao Hospital, Royal Thai Army, Bangkok, Thailand.
Background: Inguinal lymph node dissection (ILND) is the standard of care for palpable, biopsy-proven lymph node metastases or high-risk groups for nonpalpable lymph nodes in the treatment of penile cancer. ILND is associated with a significant incidence of complications and adverse events, specifically wound complications. Few studies have identified risk factors related to postoperative ILND complications.
View Article and Find Full Text PDFLate metastasis of rectal adenocarcinoma to the penis.
BMJ Case Rep
November 2024
Urology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Rectal cancer metastasising to the penis is an exceptionally rare clinical entity, with less than 80 reported cases. Metastasis to the penis is typically identified in conjunction with widespread metastatic disease and as such is usually associated with a very poor prognosis. We report a case of a man who presented with a metastatic deposit in his penis 15 years after the initial diagnosis of rectal cancer.
View Article and Find Full Text PDFPenile Metastasis-Induced Priapism as the First Sign of Lung Cancer: A Case Report and Review of the Literature.
Case Rep Urol
November 2024
Urology Department, Cliniques universitaires Saint-Luc, Avenue Hippocrate 10 1200, Brussels, Belgium.
The penis is a relatively uncommon organ for metastases. Secondary lesions often originate from the bladder, prostate, or rectosigmoid cancers. Only a few cases have described penile lesions secondary to lung cancers, mostly as a later complication.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!